Atrys Health, S.A. (BME:ATRY)
Spain
· Delayed Price · Currency is EUR 2.855
-0.070 (-2.39%)
Apr 28, 2026, 5:35 PM CET
Atrys Health Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 144.31 | 134.88 | 206.1 | 163.2 | 123.85 | Upgrade
|
| Revenue Growth (YoY) | 7.00% | -34.56% | 26.28% | 31.77% | 266.34% | Upgrade
|
| Cost of Revenue | 119.39 | 104.53 | 148.96 | 116.26 | 89.67 | Upgrade
|
| Gross Profit | 24.92 | 30.34 | 57.15 | 46.95 | 34.19 | Upgrade
|
| Selling, General & Admin | 0.73 | 0.68 | 1.84 | 2.58 | 0.68 | Upgrade
|
| Other Operating Expenses | 14.94 | 10.22 | 27.21 | 29.15 | 16.75 | Upgrade
|
| Operating Expenses | 35.32 | 30.51 | 58.73 | 57.7 | 38.22 | Upgrade
|
| Operating Income | -10.4 | -0.16 | -1.58 | -10.75 | -4.03 | Upgrade
|
| Interest Expense | -19.02 | -22.57 | -33.05 | -14.53 | -11.03 | Upgrade
|
| Interest & Investment Income | 0.6 | 0.47 | 0.63 | 2.91 | 1.85 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.07 | -1.19 | -0.04 | -0.42 | -1.32 | Upgrade
|
| Other Non Operating Income (Expenses) | 5.27 | 7.12 | 1.03 | -1.08 | 0.97 | Upgrade
|
| EBT Excluding Unusual Items | -23.48 | -16.34 | -33.01 | -23.88 | -13.57 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -11.3 | Upgrade
|
| Asset Writedown | -32.72 | -18.29 | -0.68 | -2.91 | -0.01 | Upgrade
|
| Pretax Income | -56.2 | -34.63 | -33.7 | -26.79 | -24.88 | Upgrade
|
| Income Tax Expense | -0.58 | -1.86 | -2.94 | -0.84 | -1.69 | Upgrade
|
| Earnings From Continuing Operations | -55.63 | -32.77 | -30.76 | -25.96 | -23.2 | Upgrade
|
| Earnings From Discontinued Operations | -44.92 | 0.77 | -15.14 | 2.55 | -0.05 | Upgrade
|
| Net Income to Company | -100.55 | -32.01 | -45.9 | -23.41 | -23.24 | Upgrade
|
| Minority Interest in Earnings | 0.25 | 0.23 | 0.31 | 0.26 | -0.01 | Upgrade
|
| Net Income | -100.3 | -31.77 | -45.59 | -23.15 | -23.26 | Upgrade
|
| Net Income to Common | -100.3 | -31.77 | -45.59 | -23.15 | -23.26 | Upgrade
|
| Shares Outstanding (Basic) | 76 | 76 | 76 | 68 | 50 | Upgrade
|
| Shares Outstanding (Diluted) | 76 | 76 | 76 | 68 | 50 | Upgrade
|
| Shares Change (YoY) | -0.04% | 0.16% | 11.15% | 35.64% | 77.58% | Upgrade
|
| EPS (Basic) | -1.32 | -0.42 | -0.60 | -0.34 | -0.46 | Upgrade
|
| EPS (Diluted) | -1.32 | -0.42 | -0.60 | -0.34 | -0.46 | Upgrade
|
| Free Cash Flow | -8.05 | -1.25 | -0.55 | -22.2 | 0.47 | Upgrade
|
| Free Cash Flow Per Share | -0.11 | -0.02 | -0.01 | -0.33 | 0.01 | Upgrade
|
| Gross Margin | 17.27% | 22.50% | 27.73% | 28.77% | 27.60% | Upgrade
|
| Operating Margin | -7.21% | -0.12% | -0.77% | -6.59% | -3.26% | Upgrade
|
| Profit Margin | -69.50% | -23.56% | -22.12% | -14.18% | -18.78% | Upgrade
|
| Free Cash Flow Margin | -5.58% | -0.93% | -0.27% | -13.60% | 0.38% | Upgrade
|
| EBITDA | 6.29 | 17.24 | 17.58 | 6.96 | 8.35 | Upgrade
|
| EBITDA Margin | 4.36% | 12.78% | 8.53% | 4.26% | 6.74% | Upgrade
|
| D&A For EBITDA | 16.69 | 17.4 | 19.16 | 17.71 | 12.39 | Upgrade
|
| EBIT | -10.4 | -0.16 | -1.58 | -10.75 | -4.03 | Upgrade
|
| EBIT Margin | -7.21% | -0.12% | -0.77% | -6.59% | -3.26% | Upgrade
|
| Revenue as Reported | 146.37 | 141.63 | 207 | 164.14 | 127.84 | Upgrade
|
| Advertising Expenses | 0.51 | 0.45 | 0.79 | 0.68 | 0.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.